{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["5e399cc4-8a2a-4f4d-bbd3-a910db5ffb8f", "3T", 400532589, "PRIME POLICY GROUP", 57552, "QUVA PHARMA, INC.", 2024, "third_quarter", "2024-10-14T15:03:29-04:00", 50000.0, 0, 0, 1, "{\"url\": \"https://lda.senate.gov/api/v1/filings/5e399cc4-8a2a-4f4d-bbd3-a910db5ffb8f/\", \"filing_uuid\": \"5e399cc4-8a2a-4f4d-bbd3-a910db5ffb8f\", \"filing_type\": \"3T\", \"filing_type_display\": \"3rd Quarter - Termination\", \"filing_year\": 2024, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/5e399cc4-8a2a-4f4d-bbd3-a910db5ffb8f/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"50000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Jacob Beaver\", \"dt_posted\": \"2024-10-14T15:03:29-04:00\", \"termination_date\": \"2024-09-30\", \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1801 K Street NW\", \"registrant_address_2\": \"Suite 9000\", \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20006\", \"registrant\": {\"id\": 400532589, \"url\": \"https://lda.senate.gov/api/v1/registrants/400532589/\", \"house_registrant_id\": null, \"name\": \"PRIME POLICY GROUP\", \"description\": \"Government relations\", \"address_1\": \"1801 K Street NW\", \"address_2\": \"Suite 9000\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20006\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"ABBI SOTHMANN\", \"contact_telephone\": \"+1 202-530-4574\", \"dt_updated\": \"2026-01-29T20:20:14.632389-05:00\"}, \"client\": {\"id\": 57552, \"url\": \"https://lda.senate.gov/api/v1/clients/57552/\", \"client_id\": 57552, \"name\": \"QUVA PHARMA, INC.\", \"general_description\": \"503B outsourcing facility\", \"client_government_entity\": null, \"client_self_select\": false, \"state\": \"TX\", \"state_display\": \"Texas\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"TX\", \"ppb_state_display\": \"Texas\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2023-07-21\"}, \"lobbying_activities\": [{\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Legislation and regulation impacting outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 79181, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"EMILY\", \"nickname\": null, \"middle_name\": \"AUSTEN\", \"last_name\": \"KATZ\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["5e399cc4-8a2a-4f4d-bbd3-a910db5ffb8f"], "units": {}, "query_ms": 18.69317889213562, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}